Leptin increases striatal dopamine D2 receptor binding in leptin-deficient obese (ob/ob) mice

Synapse

Volumn 64, Issue 7, 2010, Pages 503-510

  Pfaffly, Jennifer ^a   Michaelides, Michael ^a,b   Wang, Gene Jack ^b   Pessin, Jeffrey E ^a   Volkow, Nora D ^b   Thanos, Panayotis K ^a,b,c  

^a STONY BROOK UNIVERSITY   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Autoradiography; B imager; Food; Insulin; Obesity; Reward

Indexed keywords

DOPAMINE 2 RECEPTOR; INSULIN; LEPTIN; SPIPERONE;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BODY WEIGHT; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; FOOD INTAKE; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING;

ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CORPUS STRIATUM; EATING; GENOTYPE; INSULIN; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NUCLEUS ACCUMBENS; PHENOTYPE; PUTAMEN; RECEPTORS, DOPAMINE D2; SPIPERONE; TRITIUM; WEIGHT LOSS;

EID: 77953865230     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20755     Document Type: Article

References (44)

1. Baldo BA, Kelley AE. 2007. Discrete neurochemical coding of distinguishable motivational processes: Insights from nucleus accumbens control of feeding. Psychopharmacology (Berl) 191(3):439-459.
2. Baskin DG, Breininger JF, Bonigut S, Miller MA. 1999. Leptin binding in the arcuate nucleus is increased during fasting. Brain Res 828:154-158.
3. Brunetti L, Michelotto B, Orlando G, Vacca M. 1999. Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings. Eur J Pharmacol 372:237-240.
4. Carelli RM. 2002. The nucleus accumbens and reward: Neurophysiological investigations in behaving animals. Behav Cogn Neurosci Rev 1:281-296.
5. Cincotta AH, Meier AH. 1989. Reductions of body fat stores and total plasma cholesterol and triglyceride concentrations in several species by bromocriptine treatment. Life Sci 45:2247-2254.
6. Davis LM, Michaelides M, Cheskin LJ, Moran TH, Aja S, Watkins PA, Pei Z, Contoreggi C, McCullough K, Hope B, Wang GJ, Volkow ND, Thanos PK. 2008. Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity. Neuroendocrinology 89:152-162.
7. de Araujo IE, Oliveira-Maia AJ, Sotnikova TD, Gainetdinov RR, Caron MG, Nicolelis MA, Simon SA. 2008. Food reward in the absence of taste receptor signaling. Neuron 57:930-941.
8. Durant S, Coulaud J, Homo-Delarche F. 2007. Bromocriptine-induced hyperglycemia in nonobese diabetic mice: Kinetics and mechanisms of action. Rev Diabet Stud 4:185-194.
9. Farnebo LO, Hamberger B. 1971. Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices. Acta Physiol Scand Suppl 371:35-44.
10. Fetissov SO, Meguid MM, Sato T, Zhang LH. 2002. Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. Am J Physiol Regul Integr Comp Physiol 283:R905-R910.
11. Figlewicz DP. 2003. Adiposity signals and food reward: Expanding the CNS roles of insulin and leptin. Am J Physiol Regul Integr Comp Physiol 284:R882-R892.
12. Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, Pothos EN, Maratos-Flier E, Flier JS. 2006. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51:811-822.
13. Geiger BM, Behr GG, Frank LE, Caldera-Siu AD, Beinfeld MC, Kokkotou EG, Pothos EN. 2008. Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. FASEB J 22:2740-2746.
14. Green ED, Maffei M, Braden VV, Proenca R, DeSilva U, Zhang Y, Chua SC, Jr., Leibel RL, Weissenbach J, Friedman JM. 1995. The human obese (OB) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7. Genome Res 5:5-12.
15. Hagan MM, Havel PJ, Seeley RJ, Woods SC, Ekhator NN, Baker DG, Hill KK, Wortman MD, Miller AH, Gingerich RL, Geracioti TD. 1999. Cerebrospinal fluid and plasma leptin measurements: Covariability with dopamine and cortisol in fasting humans. J Clin Endocrinol Metab 84:3579-3585.
16. Hamdi A, Porter J, Prasad C. 1992. Decreased striatal D2 dopamine receptors in obese Zucker rats: Changes during aging. Brain Res 589:338-340.
17. Harris RB, Zhou J, Redmann SM Jr, Smagin GN, Smith SR, Rodgers E, Zachwieja JJ. 1998. A leptin dose-response study in obese (ob/ob) and lean (1/?) mice. Endocrinology 139:8-19. (Pubitemid 28166285)
18. Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB, Thurmon JJ, Marinelli M, DiLeone RJ. 2006. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51:801-810.
19. Jequier E. 2002. Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 967:379-388. (Pubitemid 34721923)
20. Kastin AJ, Pan W. 2000. Dynamic regulation of leptin entry into brain by the blood-brain barrier. Regul Pept 92:37-43.
21. Krugel U, Schraft T, Kittner H, Kiess W, Illes P. 2003. Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol 482:185-187.
22. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. 1995. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161.
23. Meier AH, Cincotta AH, Lovell WC. 1992. Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics. Experientia 48:248-253.
24. NAS, NRC. 1996. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press.
25. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. 1991. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48:648-654.
26. O'Doherty RM, Nguyen L. 2004. Blunted fasting-induced decreases in plasma and CSF leptin concentrations in obese rats: The role of increased leptin secretion. Int J Obes Relat Metab Disord 28:173-175.
27. Palmiter RD. 2007. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 30:375-381.
28. Pezzarossa A, Vescovi PP, Cervigni C, Angelini O, Cimicchi MC, Capretti L, Campana G, Butturini U. 1986. Effect of domperidone on the release of insulin after intravenous glucose load in man. J Endocrinol Invest 9:383-388. (Pubitemid 17224971)
29. Phillips AG, Vacca G, Ahn S. 2007. A top-down perspective on dopamine, motivation and memory. Pharmacol Biochem Behav 90:236-249.
30. Roseberry AG, Painter T, Mark GP, Williams JT. 2007. Decreased vesicular somatodendritic dopamine stores in leptin-deficient mice. J Neurosci 27:7021-7027.
31. Rubi B, Ljubicic S, Pournourmohammadi S, Carobbio S, Armanet M, Bartley C, Maechler P. 2005. Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem 280:36824-36832.
32. Sahu A. 2003. Leptin signaling in the hypothalamus: Emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol 24:225-253.
33. Salamone JD, Correa M. 2002. Motivational views of reinforcement: Implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 137:3-25.
34. Scranton RE, Gaziano JM, Rutty D, Ezrokhi M, Cincotta. 2007. A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset or placebo. BMC Endocr Disord 7:3.
35. Seufert J. 2004. Leptin effects on pancreatic β-cell gene expression and function. Diabetes 53(Suppl 1):S152-S158. (Pubitemid 38168708)
36. Seufert J, Kieffer TJ, Habener JF. 1999. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci USA 96:674-679.
37. Stice E, Spoor S, Bohon C, Small DM. 2008. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 322:449-452.
38. Szczypka MS, Rainey MA, Palmiter RD. 2000. Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nat Genet 25:102-104.
39. Thanos P, Michaelides M, Piyis Y, Wang G, Volkow N. 2008. Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([(11)C] raclopride) and in-vitro ([(3)H] spiperone) autoradiography. Synapse 62:50-61.
40. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. 1997. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7:479-484.
41. Wang G, Volkow N, Logan J, Pappas N, Wong C, Zhu W, Netusil N, Fowler J. 2001. Brain dopamine and obesity. Lancet 357:354-357.
42. Williams JM, Owens WA, Turner GH, Saunders C, Dipace C, Blakely RD, France CP, Gore JC, Daws LC, Avison MJ, Galli A. 2007. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol 5:2369-2378.
43. Wise RA. 2006. Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc Lond B Biol Sci 361:1149-1158.
44. Zhang H, Sun C, Li C, Wang S, Chen B. 1999. [Studies on changes in levels of hormone and expression of ob gene during induction of obesity in rats]. Zhonghua Yu Fang Yi Xue Za Zhi 33:218-220.